Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma

Uterine serous adenocarcinoma is a rare but highly malignant form of endometrial cancer, comprising over 50% of recurrences and deaths from endometrial cancer. We report a case of a 68-year old woman with recurrent uterine serous adenocarcinoma who underwent molecular testing and genetic sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Musselman, Kelsey, Glynn, Shannon, Mosquera, Juan Miguel, Elemento, Olivier, Sboner, Andrea, Beltran, Himisha, Holcomb, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411491/
https://www.ncbi.nlm.nih.gov/pubmed/30906838
http://dx.doi.org/10.1016/j.gore.2019.01.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411491/
https://www.ncbi.nlm.nih.gov/pubmed/30906838
http://dx.doi.org/10.1016/j.gore.2019.01.013

Ejemplares similares